Velomedix, a biotech company that makes treatments for hypothermia, has raised $3.5 million in a first round of preferred stock, according to a filing with the SEC. Based in Menlo Park, Calif., it is backed by Life Science Angels, Longitude Capital and Wavepoint Ventures.